RevTech Labs Capital

High-Level Overview

RevTech Labs Capital is a Charlotte, North Carolina-based venture capital firm founded in 2017, specializing in early-stage investments in post-revenue fintech and insurtech startups, primarily in the US and Canada.[1][2][3] Its mission centers on maximizing founder success through capital deployment, accelerator programs, and ecosystem connections, often in partnership with the RevTech Labs Foundation, a 501(c)(3) nonprofit that runs tailored 12-week hybrid accelerators for post-MVP, pre-Series A companies.[2][3][4][6] The firm's investment philosophy emphasizes $200k-$400k average checks in accelerator participants, follow-on funding for alumni, and select external deals, with over half of its portfolio featuring female founders or founders of color; it has backed 273 companies, driven $2.5B+ in total raised capital across 250+ alumni, and created 1,200+ jobs.[1][2][4] In the startup ecosystem, it fosters diversity, provides 500+ SME mentors and 400+ VC partners, and hosts events like demo days to boost visibility and growth in finance and insurance tech.[4][6]

Origin Story

RevTech Labs originated in 2012 from Packard Place in Charlotte, initially accelerating general tech entrepreneurship before pivoting in 2015 to Queen City Fintech, honing a sharp focus on fintech amid rapid success.[3] This evolution birthed RevTech Labs Capital (formerly CFV Ventures) in 2017 as a $10MM seed and Series A fund, investing in every accelerator company and select external fintech, insurtech, and healthtech startups.[1][2][3] Key figures include Co-founder and General Partner Daniel Roselli, General Partner Kenneth Gacevich, and Venture Partners Josh Brant and Nakeita "Nikki" Norman.[5] Milestones include launching IBM's global HyperProtect Accelerator in 2019 alongside a healthtech program, forming the RevTech Labs Foundation nonprofit in 2020 to address diversity gaps, Fund 2 in 2022, and relocating in 2025 to UNC Charlotte's CO-LAB innovation hub.[3]

Core Differentiators

• Unique Investment Model: Invests in all accelerator entrants via its strategic partnership with RevTech Labs Foundation, plus follow-ons and external Series A deals in fintech/insurtech/healthtech; holds equity stakes for revenue while customizing 12-week programs around founder micro-goals.[2][3][6]
• Network Strength: 500+ SME mentors matched via pitch surveys, 400+ VC firm partners, corporate connections (e.g., IBM), and global reach with US expansion focus for international startups; events like Mentor Matchmaking and Demo Days amplify visibility.[4][6]
• Track Record: 273 portfolio companies (e.g., Kredete, iink Payments, Chaiz), 18 exits, 44 deals in last 2 years (17 in last 12 months), $2.5B+ alumni capital raised, 1,200+ jobs; diversity emphasis with >50% portfolio having female/founder-of-color teams.[1][2][4]
• Operating Support: Founder-centric with tailored advisory boards, pitch training, investor intros, and strategy sprints; alumni testimonials highlight accelerated growth, customer acquisition, and funding via deep fintech expertise.[4][6]

Role in the Broader Tech Landscape

RevTech Labs Capital rides the fintech/insurtech boom, capitalizing on digital transformation in finance and insurance amid rising demand for innovative, post-revenue solutions post-2020 disruptions like remote banking and healthtech integration.[3] Timing aligns with Charlotte's emergence as a tech hub—bolstered by its 2025 CO-LAB move and North Tryon Tech Hub role—countering traditional VC concentration in coastal cities by building a diverse, founder-focused ecosystem in the Southeast US.[3][4] Market forces like global fintech funding resurgence, insurtech scalability via AI/ML, and equity gaps favor its model, influencing the ecosystem through alumni scaling (e.g., $2.5B raised), job creation, and national roadshows that connect startups to corporates and VCs, disrupting inequities while elevating regional entrepreneurship.[2][4]

Quick Take & Future Outlook

RevTech Labs Capital is poised to scale with Fund 2 momentum and CO-LAB's academic synergies, likely deepening healthtech bets amid AI-driven insurtech evolution and US market expansions for global alumni.[3] Trends like embedded finance, regulatory tailwinds for fintech, and diversity mandates will propel deal flow beyond recent 17 annual investments, potentially hitting more exits as its 273-company portfolio matures. Its influence may grow by exporting Charlotte's model nationally, solidifying its niche as the go-to accelerator-VC hybrid for underrepresented fintech founders—echoing its 2012 origins in fueling high-potential, post-revenue disruptors.[1][2][4]